Summary

Market Overview:

The global ulcerative colitis market size reached US$ 7.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028.

Ulcerative colitis (UC) refers to a chronic inflammatory bowel disease (IBD) that causes irritation, inflammation, and ulcers (sores) in the digestive tract. It typically affects the inner lining of the large intestine (or colon) and rectum. The symptoms generally develop over time, and individuals diagnosed with UC may experience periods of mild or no symptoms. However, it can sometimes lead to debilitating or life-threatening complications. While there is no cure for UC yet, the treatment can help patients manage and reduce their symptoms, prevent flare-ups, and bring about long-term remission. As a result, UC treatment is rapidly gaining traction across the globe as it can help enhance the quality of life and ensure the physical and mental wellbeing of the patients.

Ulcerative Colitis Market Trends:
The widespread prevalence of UC disease and the rising awareness regarding the available treatment options represent the primary factors driving the market growth. Besides this, the presence of strong pipeline products and continuous advancements in numerous drugs are augmenting the product demand. Additionally, governments of various countries are taking several initiatives to spread awareness about the condition and enhance the accessibility and availability of proper healthcare facilities. This, in confluence with the increasing investments in the research and development (R&D) activities for the development of novel therapies, is propelling the market growth. Furthermore, the leading players are focusing on launching innovative and more effective drugs to expand their product portfolio and gain a competitive edge in the market. Other factors, including the easy availability of biosimilar drugs, improving healthcare infrastructure, favorable reimbursement policies, and increasing consumer spending on healthcare, are also creating a positive market outlook.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global ulcerative colitis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, disease type, molecule type, drug type, route of administration and distribution channel.

Breakup by Type:

Mild UC
Moderate UC
Severe UC

Breakup by Disease Type:

Ulcerative Proctitis
Proctosigmoiditis
Left-sided Colitis
Pancolitis or Universal Colitis
Fulminant Colitis

Breakup by Molecule Type:

Small Molecules
Biologics

Breakup by Drug Type:

Anti-Inflammatory Drugs
Anti-TNF Biologics
Immunosuppressant
Calcineurin Inhibitors
Others

Breakup by Route of Administration:

Oral
Injectable

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Store
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:
How has the global ulcerative colitis market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global ulcerative colitis market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the disease type?
What is the breakup of the market based on the molecule type?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global ulcerative colitis market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Ulcerative Colitis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Mild UC
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Moderate UC
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Severe UC
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Disease Type
7.1 Ulcerative Proctitis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Proctosigmoiditis
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Left-sided Colitis
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pancolitis or Universal Colitis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Fulminant Colitis
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Molecule Type
8.1 Small Molecules
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Biologics
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Drug Type
9.1 Anti-Inflammatory Drugs
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Anti-TNF Biologics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Immunosuppressant
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Calcineurin Inhibitors
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Route of Administration
10.1 Oral
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Injectable
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by Distribution Channel
11.1 Hospital Pharmacies
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Retail Pharmacies
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Drug Store
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Others
11.4.1 Market Trends
11.4.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Abbott Laboratories
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 AbbVie Inc.
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.2.3 Financials
17.3.2.4 SWOT Analysis
17.3.3 AstraZeneca plc
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.3.3 Financials
17.3.3.4 SWOT Analysis
17.3.4 Bristol-Myers Squibb Company
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.4.3 Financials
17.3.4.4 SWOT Analysis
17.3.5 Eli Lilly and Company
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 F. Hoffmann-La Roche Ltd.
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.6.3 Financials
17.3.7 GlaxoSmithKline plc
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 Financials
17.3.7.4 SWOT Analysis
17.3.8 Johnson & Johnson
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.8.4 SWOT Analysis
17.3.9 Merck & Co. Inc.
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.9.3 Financials
17.3.9.4 SWOT Analysis
17.3.10 Pfizer Inc.
17.3.10.1 Company Overview
17.3.10.2 Product Portfolio
17.3.10.3 Financials
17.3.10.4 SWOT Analysis
17.3.11 Takeda Pharmaceutical Company Limited
17.3.11.1 Company Overview
17.3.11.2 Product Portfolio
17.3.11.3 Financials
17.3.11.4 SWOT Analysis
17.3.12 Teva Pharmaceutical Industries Ltd.
17.3.12.1 Company Overview
17.3.12.2 Product Portfolio
17.3.12.3 Financials
17.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Ulcerative Colitis Market: Major Drivers and Challenges
Figure 2: Global: Ulcerative Colitis Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Ulcerative Colitis Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Ulcerative Colitis Market: Breakup by Type (in %), 2022
Figure 5: Global: Ulcerative Colitis Market: Breakup by Disease Type (in %), 2022
Figure 6: Global: Ulcerative Colitis Market: Breakup by Molecule Type (in %), 2022
Figure 7: Global: Ulcerative Colitis Market: Breakup by Drug Type (in %), 2022
Figure 8: Global: Ulcerative Colitis Market: Breakup by Route of Administration (in %), 2022
Figure 9: Global: Ulcerative Colitis Market: Breakup by Distribution Channel (in %), 2022
Figure 10: Global: Ulcerative Colitis Market: Breakup by Region (in %), 2022
Figure 11: Global: Ulcerative Colitis (Mild UC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Ulcerative Colitis (Mild UC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Ulcerative Colitis (Moderate UC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Ulcerative Colitis (Moderate UC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Ulcerative Colitis (Severe UC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Ulcerative Colitis (Severe UC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Ulcerative Colitis (Ulcerative Proctitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Ulcerative Colitis (Ulcerative Proctitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Ulcerative Colitis (Proctosigmoiditis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Ulcerative Colitis (Proctosigmoiditis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Ulcerative Colitis (Left-sided Colitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Ulcerative Colitis (Left-sided Colitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Ulcerative Colitis (Pancolitis or Universal Colitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Ulcerative Colitis (Pancolitis or Universal Colitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Ulcerative Colitis (Fulminant Colitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Ulcerative Colitis (Fulminant Colitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Ulcerative Colitis (Small Molecules) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Ulcerative Colitis (Small Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Ulcerative Colitis (Biologics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Ulcerative Colitis (Biologics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Ulcerative Colitis (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Ulcerative Colitis (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Ulcerative Colitis (Anti-TNF Biologics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Ulcerative Colitis (Anti-TNF Biologics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Ulcerative Colitis (Immunosuppressant) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Ulcerative Colitis (Immunosuppressant) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Ulcerative Colitis (Calcineurin Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Ulcerative Colitis (Calcineurin Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Ulcerative Colitis (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Ulcerative Colitis (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Ulcerative Colitis (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Ulcerative Colitis (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: Ulcerative Colitis (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: Ulcerative Colitis (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Global: Ulcerative Colitis (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Global: Ulcerative Colitis (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Global: Ulcerative Colitis (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Global: Ulcerative Colitis (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Global: Ulcerative Colitis (Drug Store) Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Global: Ulcerative Colitis (Drug Store) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Global: Ulcerative Colitis (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Global: Ulcerative Colitis (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: North America: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: North America: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: United States: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: United States: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Canada: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Canada: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Asia-Pacific: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Asia-Pacific: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: China: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: China: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Japan: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Japan: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: India: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: India: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: South Korea: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: South Korea: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Australia: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Australia: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Indonesia: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Indonesia: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Europe: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Europe: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Germany: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Germany: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: France: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: France: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: United Kingdom: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: United Kingdom: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Italy: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Italy: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Spain: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Spain: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Russia: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Russia: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Others: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Others: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Latin America: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Latin America: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 93: Brazil: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 94: Brazil: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 95: Mexico: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 96: Mexico: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 97: Others: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 98: Others: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 99: Middle East and Africa: Ulcerative Colitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 100: Middle East and Africa: Ulcerative Colitis Market: Breakup by Country (in %), 2022
Figure 101: Middle East and Africa: Ulcerative Colitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 102: Global: Ulcerative Colitis Industry: SWOT Analysis
Figure 103: Global: Ulcerative Colitis Industry: Value Chain Analysis
Figure 104: Global: Ulcerative Colitis Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Ulcerative Colitis Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Ulcerative Colitis Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Ulcerative Colitis Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
Table 4: Global: Ulcerative Colitis Market Forecast: Breakup by Molecule Type (in Million US$), 2023-2028
Table 5: Global: Ulcerative Colitis Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 6: Global: Ulcerative Colitis Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 7: Global: Ulcerative Colitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 8: Global: Ulcerative Colitis Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 9: Global: Ulcerative Colitis Market: Competitive Structure
Table 10: Global: Ulcerative Colitis Market: Key Players